Ipamorelin, the First Selective Growth Hormone Secretagogue
Retatrutide is a groundbreaking triple agonist currently in Phase 3 trials that is redefining what is possible without surgery: Triple-Action Mechanism: Unlike Wegovy (1 receptor) or Zepbound (2 receptors), Retatrutide targets three hormones: GLP-1, GIP, and Glucagon
The effects on the brain of GLP-1 analogues go far beyond satiety but may also change food preferences in a healthier direction, but also reduce a persons drive for alcohol, tobacco and even opioids
Zoe B.Treatment Knowledge, River North Chicago GLP-1 Weight Loss Treatments What You Can Expect Bespoke Consultation Your provider will review your medical history, body composition, and weight-loss goals
Renal function: mild eGFR changes observed in some patients